Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Assessing Treatment Response and Prognosis by Serum and Tissue Metabolomics in Breast Cancer Patients.

Debik J, Euceda LR, Lundgren S, Gythfeldt HVL, Garred Ø, Borgen E, Engebraaten O, Bathen TF, Giskeødegård GF.

J Proteome Res. 2019 Oct 4;18(10):3649-3660. doi: 10.1021/acs.jproteome.9b00316. Epub 2019 Sep 16.

PMID:
31483662
2.

Serum levels of inflammation-related markers and metabolites predict response to neoadjuvant chemotherapy with and without bevacizumab in breast cancers.

Nome ME, Euceda LR, Jabeen S, Debik J, Bathen TF, Giskeødegård GF, Taskén KA, Maelandsmo GM, Halvorsen B, Yndestad A, Borgen E, Garred Ø, Aukrust P, Ueland T, Engebraaten O, Kristensen VN, Tekpli X.

Int J Cancer. 2019 Aug 24. doi: 10.1002/ijc.32638. [Epub ahead of print]

PMID:
31444972
3.

Toward Personalized Computer Simulation of Breast Cancer Treatment: A Multiscale Pharmacokinetic and Pharmacodynamic Model Informed by Multitype Patient Data.

Lai X, Geier OM, Fleischer T, Garred Ø, Borgen E, Funke SW, Kumar S, Rognes ME, Seierstad T, Børresen-Dale AL, Kristensen VN, Engebraaten O, Köhn-Luque A, Frigessi A.

Cancer Res. 2019 Aug 15;79(16):4293-4304. doi: 10.1158/0008-5472.CAN-18-1804. Epub 2019 May 22.

PMID:
31118201
4.

Breast cancer quantitative proteome and proteogenomic landscape.

Johansson HJ, Socciarelli F, Vacanti NM, Haugen MH, Zhu Y, Siavelis I, Fernandez-Woodbridge A, Aure MR, Sennblad B, Vesterlund M, Branca RM, Orre LM, Huss M, Fredlund E, Beraki E, Garred Ø, Boekel J, Sauer T, Zhao W, Nord S, Höglander EK, Jans DC, Brismar H, Haukaas TH, Bathen TF, Schlichting E, Naume B; Consortia Oslo Breast Cancer Research Consortium (OSBREAC), Luders T, Borgen E, Kristensen VN, Russnes HG, Lingjærde OC, Mills GB, Sahlberg KK, Børresen-Dale AL, Lehtiö J.

Nat Commun. 2019 Apr 8;10(1):1600. doi: 10.1038/s41467-019-09018-y.

5.

Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.

Höglander EK, Nord S, Wedge DC, Lingjærde OC, Silwal-Pandit L, Gythfeldt HV, Vollan HKM, Fleischer T, Krohn M, Schlitchting E, Borgen E, Garred Ø, Holmen MM, Wist E, Naume B, Van Loo P, Børresen-Dale AL, Engebraaten O, Kristensen V.

Genome Med. 2018 Nov 29;10(1):92. doi: 10.1186/s13073-018-0601-y.

6.

Subtype-specific clinical and prognostic relevance of tumor-expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study.

Tinholt M, Garred Ø, Borgen E, Beraki E, Schlichting E, Kristensen V, Sahlberg KK, Iversen N.

J Thromb Haemost. 2018 Jul;16(7):1347-1356. doi: 10.1111/jth.14151. Epub 2018 Jun 12.

PMID:
29766637
7.

Multicellular tumor spheroids of human uveal melanoma induce genes associated with anoikis resistance, lipogenesis, and SSXs.

Ness C, Garred Ø, Eide NA, Kumar T, Olstad OK, Bærland TP, Petrovski G, Moe MC, Noer A.

Mol Vis. 2017 Oct 3;23:680-694. eCollection 2017.

8.

Erratum: Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer.

Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I.

NPJ Breast Cancer. 2017 Sep 5;3:35. doi: 10.1038/s41523-017-0030-x. eCollection 2017.

9.

Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer.

Vaysse C, Lømo J, Garred Ø, Fjeldheim F, Lofteroed T, Schlichting E, McTiernan A, Frydenberg H, Husøy A, Lundgren S, Fagerland MW, Richardsen E, Wist EA, Muller C, Thune I.

NPJ Breast Cancer. 2017 May 3;3:19. doi: 10.1038/s41523-017-0015-9. eCollection 2017. Erratum in: NPJ Breast Cancer. 2017 Sep 5;3:35.

10.

The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer.

Silwal-Pandit L, Nord S, von der Lippe Gythfeldt H, Møller EK, Fleischer T, Rødland E, Krohn M, Borgen E, Garred Ø, Olsen T, Vu P, Skjerven H, Fangberget A, Holmen MM, Schlitchting E, Wille E, Nordberg Stokke M, Moen Vollan HK, Kristensen V, Langerød A, Lundgren S, Wist E, Naume B, Lingjærde OC, Børresen-Dale AL, Engebraaten O.

Clin Cancer Res. 2017 Aug 15;23(16):4662-4670. doi: 10.1158/1078-0432.CCR-17-0160. Epub 2017 May 9.

11.

Determinants of acquired activated protein C resistance and D-dimer in breast cancer.

Tinholt M, Sandset PM, Mowinckel MC, Garred Ø, Sahlberg KK, Kristensen VN, Børresen-Dale AL, Jacobsen AF, Skretting G, Iversen N.

Thromb Res. 2016 Sep;145:78-83. doi: 10.1016/j.thromres.2016.08.003. Epub 2016 Aug 3.

PMID:
27505249
12.

Direct Transcriptional Consequences of Somatic Mutation in Breast Cancer.

Shlien A, Raine K, Fuligni F, Arnold R, Nik-Zainal S, Dronov S, Mamanova L, Rosic A, Ju YS, Cooke SL, Ramakrishna M, Papaemmanuil E, Davies HR, Tarpey PS, Van Loo P, Wedge DC, Jones DR, Martin S, Marshall J, Anderson E, Hardy C; ICGC Breast Cancer Working Group, Oslo Breast Cancer Research Consortium, Barbashina V, Aparicio SA, Sauer T, Garred Ø, Vincent-Salomon A, Mariani O, Boyault S, Fatima A, Langerød A, Borg Å, Thomas G, Richardson AL, Børresen-Dale AL, Polyak K, Stratton MR, Campbell PJ.

Cell Rep. 2016 Aug 16;16(7):2032-46. doi: 10.1016/j.celrep.2016.07.028. Epub 2016 Aug 4.

13.

Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes.

Haukaas TH, Euceda LR, Giskeødegård GF, Lamichhane S, Krohn M, Jernström S, Aure MR, Lingjærde OC, Schlichting E, Garred Ø, Due EU, Mills GB, Sahlberg KK, Børresen-Dale AL, Bathen TF; Oslo Breast Cancer Consortium (OSBREAC).

Cancer Metab. 2016 Jun 27;4:12. doi: 10.1186/s40170-016-0152-x. eCollection 2016.

14.

Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.

Flote VG, Vettukattil R, Bathen TF, Egeland T, McTiernan A, Frydenberg H, Husøy A, Finstad SE, Lømo J, Garred Ø, Schlichting E, Wist EA, Thune I.

Lipids Health Dis. 2016 Mar 12;15:56. doi: 10.1186/s12944-016-0225-4.

15.

Bilateral uveal melanomas with different gene expression detected with 7 years interval.

Eide N, Garred Ø, Beiske K, Fodstad Ø.

Acta Ophthalmol. 2016 Feb;94(1):99-102. doi: 10.1111/aos.12857. Epub 2015 Oct 24.

16.

Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study.

Chen Y, Klingen TA, Wik E, Aas H, Vigeland E, Liestøl K, Garred Ø, Mæhlen J, Akslen LA, Lømo J.

Diagn Pathol. 2014 Dec 19;9:230. doi: 10.1186/s13000-014-0230-8.

17.

Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.

Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N.

BMC Cancer. 2014 Nov 19;14:845. doi: 10.1186/1471-2407-14-845.

18.

Structural requirements for furin-induced cleavage and activation of Shiga toxin.

Kurmanova A, Llorente A, Polesskaya A, Garred O, Olsnes S, Kozlov J, Sandvig K.

Biochem Biophys Res Commun. 2007 May 25;357(1):144-9. Epub 2007 Mar 28.

PMID:
17407762
20.
22.
23.

Apical macropinocytosis in polarized MDCK cells: regulation by N-ethylmaleimide-sensitive proteins.

Sandvig K, Llorente A, Rodal SK, Eker P, Garred O, Stahlhut M, van Deurs B.

Eur J Cell Biol. 2000 Jul;79(7):447-57.

PMID:
10961444
24.

Apical endocytosis of ricin in MDCK cells is regulated by the cyclooxygenase pathway.

Llorente A, van Deurs B, Garred O, Eker P, Sandvig K.

J Cell Sci. 2000 Apr;113 ( Pt 7):1213-21.

25.

Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles.

Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, Sandvig K.

Mol Biol Cell. 1999 Apr;10(4):961-74.

26.

[Self-inhibiting N-glycosidase activity of shigella toxin].

Polesskaia AN, Garred O, Olsnes S, Kozlov IuV.

Mol Biol (Mosk). 1997 May-Jun;31(3):528-35. Russian. No abstract available.

PMID:
9297098
27.

Role of the disulfide bond in Shiga toxin A-chain for toxin entry into cells.

Garred O, Dubinina E, Polesskaya A, Olsnes S, Kozlov J, Sandvig K.

J Biol Chem. 1997 Apr 25;272(17):11414-9.

28.

Intracellular transport and processing of protein toxins produced by enteric bacteria.

Sandvig K, Garred O, van Deurs B.

Adv Exp Med Biol. 1997;412:225-32. Review.

PMID:
9192018
29.

Thapsigargin-induced transport of cholera toxin to the endoplasmic reticulum.

Sandvig K, Garred O, van Deurs B.

Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12339-43.

30.

Effect of calmodulin antagonists on endocytosis and intracellular transport of ricin in polarized MDCK cells.

Llorente A, Garred O, Holm PK, Eker P, Jacobsen J, van Deurs B, Sandvig K.

Exp Cell Res. 1996 Sep 15;227(2):298-308.

PMID:
8831568
31.

Importance of glycolipid synthesis for butyric acid-induced sensitization to shiga toxin and intracellular sorting of toxin in A431 cells.

Sandvig K, Garred O, van Helvoort A, van Meer G, van Deurs B.

Mol Biol Cell. 1996 Sep;7(9):1391-404.

33.

Furin-induced cleavage and activation of Shiga toxin.

Garred O, van Deurs B, Sandvig K.

J Biol Chem. 1995 May 5;270(18):10817-21.

34.

Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants.

Garred O, Dubinina E, Holm PK, Olsnes S, van Deurs B, Kozlov JV, Sandvig K.

Exp Cell Res. 1995 May;218(1):39-49.

PMID:
7737376
35.
36.

Endocytosis and intracellular transport of protein toxins.

Sandvig K, Garred O, Holm PK, van Deurs B.

Biochem Soc Trans. 1993 Aug;21 ( Pt 3)(3):707-11. Review. No abstract available.

PMID:
8224494
37.

Entry of Shiga toxin into cells.

Sandvig K, Dubinina E, Garred O, Prydz K, Kozlov JV, Hansen SH, Van Deurs B.

Zentralbl Bakteriol. 1993 Apr;278(2-3):296-305.

PMID:
8347933
38.

Protein toxins: mode of action and cell entry.

Sandvig K, Dubinina E, Garred O, Prydz K, Kozlov JV, Hansen SH, van Deurs B.

Biochem Soc Trans. 1992 Nov;20(4):724-7. Review. No abstract available.

PMID:
1487049
39.

Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum.

Sandvig K, Garred O, Prydz K, Kozlov JV, Hansen SH, van Deurs B.

Nature. 1992 Aug 6;358(6386):510-2.

PMID:
1641040

Supplemental Content

Loading ...
Support Center